The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients.
Li M, Xue SL, Tang X, Xu J, Chen S, Han Y, Qiu H, Miao M, Xu N, Tan J, Kang L, Yu Z, Lou X, Xu Y, Chen J, Yan Z, Feng W, Wu D, Yu L.
Li M, et al. Among authors: chen j, chen s.
Sci Rep. 2022 Jan 10;12(1):378. doi: 10.1038/s41598-021-04296-3.
Sci Rep. 2022.
PMID: 35013456
Free PMC article.
Clinical Trial.